Cubist Systematic Strategies, LLC Mustang Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.02 - $5.16 $89,392 - $152,736	-29,600 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.66 - $4.18 $78,736 - $123,727	29,600 New	29,600 $112,000
Q3 2020 Nov 16, 2020	SELL	$3.01 - $3.88 $78,738 - $101,496	-26,159 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.33 - $4.6 $60,950 - $120,331	26,159 New	26,159 $83,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $24.2M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.